Abbott profit jumps as all business units shine (Reuters)

Reuters – Abbott Laboratories said on Wednesday fourth-quarter earnings jumped 28 percent on demand for its prescription drugs, nutritional products and medical devices, including its new Xience stent used to prop open coronary arteries.

Leave a Reply